

Cover Story
More than a decade ago, Glenn Begley and Lee Ellis published a paper with astounding findings: of 53 “landmark” studies, only six, or 11%, were reproducible, even with the same reagents and the same protocols—and even, sometimes, in the same laboratory—as the original study.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
NCI Trials


NCI Trials for February 2024
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Vermont researchers discover transmissible cancer in catfish—first ever in a freshwater animal
- The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer
















